Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria (Q38160759)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

30 August 2017

Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria (English)

1 reference

Europe PubMed Central

30 August 2017

pregnant person

1 reference

based on heuristic

inferred from title

urinary tract infection

1 reference

based on heuristic

inferred from title

Gillian M Keating

1

object named as

Gillian M Keating

1 reference

Europe PubMed Central

30 August 2017

publication date

1 November 2013

1 reference

Europe PubMed Central

30 August 2017

1 reference

Europe PubMed Central

30 August 2017

73

1 reference

Europe PubMed Central

30 August 2017

17

1 reference

Europe PubMed Central

30 August 2017

1951-1966

1 reference

Europe PubMed Central

30 August 2017

https://scigraph.springernature.com/pub.10.1007/s40265-013-0143-y

0 references

Clinical practice. Uncomplicated urinary tract infection

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

The mechanism of action of fosfomycin (phosphonomycin)

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Revisiting "older" antimicrobials in the era of multidrug resistance

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Susceptibility of urinary tract bacteria to fosfomycin

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Fosfomycin: an oral agent for urinary infection caused by extended spectrum beta-lactamase producing organisms

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Fosfomycin tromethamine in uncomplicated urinary tract infections: a clinical study

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

In vitro susceptibility of community-acquired urinary tract pathogens to commonly used antimicrobial agents in Spain: a comparative multicenter study (2002-2004).

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Management of biofilm infections in the urinary tract

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Biological costs and mechanisms of fosfomycin resistance in Escherichia coli

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Plasmid-encoded fosfomycin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Purification of a glutathione S-transferase that mediates fosfomycin resistance in bacteria

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Etiology of community-acquired lower urinary infections and antimicrobial resistance of Escherichia coli: a national surveillance study

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Changes in the antimicrobial susceptibility of Escherichia coli isolates from nosocomial versus community-acquired urinary tract infections

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Antibiotic resistance transformation in community-acquired urinary infections

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

[Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?]

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

In-vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Pharmacokinetic profile of fosfomycin trometamol.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Fosfomycin in a single dose versus a 7-day course of amoxicillin-clavulanate for the treatment of asymptomatic bacteriuria during pregnancy

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Treatment of lower urinary tract infection in pregnancy

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Single-dose fosfomycin trometamol versus multiple-dose cotrimoxazole in the treatment of lower urinary tract infections in general practice. Multicenter Group of General Practitioners

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Fosfomycin trometamol versus norfloxacin in the treatment of uncomplicated lower urinary tract infections of the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

A general practitioner multicenter study: fosfomycin trometamol single dose versus pipemidic acid multiple dose.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Single dose and conventional treatment for acute bacterial and non-bacterial dysuria and frequency in general practice

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Multidrug-resistant Gram-negative infections: what are the treatment options?

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Why fosfomycin trometamol as first line therapy for uncomplicated UTI?

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Antibiotic treatment of uncomplicated urinary tract infection in premenopausal women

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Randomized comparative study for the assessment of a new therapeutic schedule of fosfomycin trometamol in postmenopausal women with uncomplicated lower urinary tract infection

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections.

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Prophylactic chemotherapy with fosfomycin trometamol versus placebo during transurethral prostatic resection

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Prophylactic chemotherapy with fosfomycin trometamol during transurethral surgery and urological manoeuvres. Results of a multicentre study

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Fosfomycin trometamol versus netilmicin in children's lower urinary tract infections

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0143-Y

21 January 2018

Fosfomycin in vitro resistance of Escherichia coli from the community

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of fosfomycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of lower urinary tract infections in children: single dose fosfomycin trometamol versus pipemidic acid.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single dose fosfomycin trometamol versus multiple dose norfloxacin over three days for uncomplicated UTI in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trometamol-fosfomycin (Monuril) bioavailability and food-drug interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monuril in lower uncomplicated urinary tract infections in adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trometamol salt of fosfomycin (Monuril). Preliminary pharmacokinetic and clinical experience in the treatment of urinary tract infections in children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Microorganisms isolated from outpatient urine samples and antimicrobial susceptibility over a 12-year period]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microbiological basis for the use of fosfomycin trometamol as single-dose therapy for simple cystitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monuril and modification of pathogenicity traits in resistant microorganisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary concentrations of fosfomycin after a single 3 g dose of fosfomycin to elderly nursing-home patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is single-dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimesterof pregnancy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic profile of fosfomycin trometamol (Monuril)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic chemotherapy with fosfomycin trometamol salt during transurethral prostatic surgery: a controlled multicenter clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary tract infections in pregnancy: Monuril single-dose treatment versus traditional therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of single-dose and multiple-dose antibiotics for lower urinary tract infection in pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[AFSSAPS Practice recommendations for diagnosis and antibiotic therapy of adult community urinary tract infections]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect and pharmacokinetics of netilmicin given as bolus intramuscular administration: an open comparative trial versus amikacin and fosfomycin in elderly patients affected by urinary tract infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose antibacterial treatment for bacteriuria in pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fosfomycin trometamol versus amoxycillin--single-dose multicenter study of urinary tract infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of fosfomycin and other antimicrobials against uropathogenic Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic prescription by general practitioners for urinary tract infections in outpatients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and treatment of acute uncomplicated cystitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trometamol salt of fosfomycin versus netilmicin: randomized multicenter study in children's lower urinary tract infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fosfomycin trometamol versus pipemidic acid in the treatment of bacteriuria in pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Chemoprevention using fosfomycin trometamol in transurethral resection of the prostate: multicenter controlled clinical study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative double-blind randomised study of single dose fosfomycin trometamol with trimethoprim in the treatment of urinary tract infections in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro susceptibility of enterococci strains isolated from urine samples to fosfomycin and other antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/24202878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40265-013-0143-Y

1 reference

Europe PubMed Central

30 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

30 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38160759&oldid=1744201722"